Concepts (208)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Directed Tissue Donation | 1 | 2020 | 8 | 0.89 | Why? |
| Greece | 14 | 2021 | 2091 | 0.78 | Why? |
| Quasispecies | 1 | 2020 | 108 | 0.78 | Why? |
| Helicobacter Infections | 2 | 2019 | 216 | 0.76 | Why? |
| Helicobacter pylori | 2 | 2019 | 262 | 0.75 | Why? |
| INDEL Mutation | 1 | 2018 | 128 | 0.71 | Why? |
| Carcinogenesis | 1 | 2019 | 236 | 0.65 | Why? |
| Poliovirus | 1 | 2017 | 109 | 0.62 | Why? |
| Blood Component Transfusion | 1 | 2020 | 740 | 0.58 | Why? |
| Blood Safety | 1 | 2020 | 459 | 0.58 | Why? |
| Donor Selection | 1 | 2020 | 804 | 0.52 | Why? |
| Stomach Neoplasms | 1 | 2019 | 477 | 0.51 | Why? |
| Viremia | 1 | 2020 | 1020 | 0.50 | Why? |
| Enterovirus | 1 | 2017 | 402 | 0.50 | Why? |
| Terminology as Topic | 1 | 2018 | 546 | 0.49 | Why? |
| Polymorphism, Genetic | 1 | 2020 | 1074 | 0.49 | Why? |
| Sewage | 1 | 2017 | 591 | 0.44 | Why? |
| Emigration and Immigration | 1 | 2016 | 501 | 0.44 | Why? |
| Human Rights | 1 | 2016 | 618 | 0.37 | Why? |
| Laboratories | 3 | 2020 | 2858 | 0.34 | Why? |
| Multiple Sclerosis | 3 | 2017 | 2600 | 0.33 | Why? |
| Blood Donors | 1 | 2020 | 2956 | 0.32 | Why? |
| Refugees | 1 | 2016 | 809 | 0.32 | Why? |
| Computational Biology | 2 | 2020 | 4514 | 0.32 | Why? |
| Environmental Monitoring | 1 | 2017 | 3143 | 0.27 | Why? |
| Feces | 1 | 2017 | 4235 | 0.25 | Why? |
| Measles | 2 | 2018 | 608 | 0.21 | Why? |
| Platelet-Rich Plasma | 1 | 2020 | 91 | 0.20 | Why? |
| Influenza Vaccines | 1 | 2016 | 2941 | 0.20 | Why? |
| Embryonal Carcinoma Stem Cells | 1 | 2018 | 2 | 0.20 | Why? |
| Drug Resistance, Multiple | 1 | 2020 | 156 | 0.20 | Why? |
| ras Guanine Nucleotide Exchange Factors | 1 | 2018 | 3 | 0.20 | Why? |
| Antigens | 1 | 2021 | 267 | 0.19 | Why? |
| Virus Diseases | 2 | 2018 | 3779 | 0.18 | Why? |
| Endogenous Retroviruses | 1 | 2018 | 72 | 0.18 | Why? |
| Virus Integration | 1 | 2018 | 96 | 0.18 | Why? |
| Artifacts | 1 | 2020 | 250 | 0.18 | Why? |
| Genome, Viral | 1 | 2020 | 13157 | 0.18 | Why? |
| Respiratory Tract Infections | 3 | 2018 | 6817 | 0.18 | Why? |
| Police | 1 | 2020 | 243 | 0.18 | Why? |
| Genome, Human | 2 | 2018 | 400 | 0.17 | Why? |
| Therapy, Computer-Assisted | 1 | 2017 | 39 | 0.17 | Why? |
| Influenza B virus | 2 | 2016 | 815 | 0.17 | Why? |
| Cardiotonic Agents | 1 | 2020 | 418 | 0.17 | Why? |
| Drug Substitution | 1 | 2020 | 385 | 0.16 | Why? |
| Homocysteine | 1 | 2017 | 83 | 0.16 | Why? |
| Genetic Drift | 1 | 2016 | 54 | 0.16 | Why? |
| Measles virus | 1 | 2018 | 194 | 0.16 | Why? |
| Enterovirus B, Human | 1 | 2017 | 124 | 0.16 | Why? |
| Vitamin B 12 | 1 | 2017 | 132 | 0.16 | Why? |
| Folic Acid | 1 | 2017 | 172 | 0.15 | Why? |
| Compassionate Use Trials | 1 | 2020 | 632 | 0.15 | Why? |
| Molecular Typing | 1 | 2017 | 280 | 0.15 | Why? |
| Superinfection | 1 | 2020 | 459 | 0.15 | Why? |
| Influenza, Human | 2 | 2020 | 10779 | 0.15 | Why? |
| Measles Vaccine | 1 | 2018 | 301 | 0.14 | Why? |
| Vaccine Potency | 1 | 2016 | 339 | 0.14 | Why? |
| Peer Review, Research | 1 | 2018 | 407 | 0.13 | Why? |
| Substance Abuse, Intravenous | 1 | 2018 | 411 | 0.13 | Why? |
| Leukemia, Myeloid, Acute | 1 | 2020 | 676 | 0.13 | Why? |
| Child, Preschool | 8 | 2021 | 36283 | 0.12 | Why? |
| Quaternary Ammonium Compounds | 1 | 1994 | 136 | 0.12 | Why? |
| Poliomyelitis | 1 | 2017 | 263 | 0.12 | Why? |
| Transcription, Genetic | 1 | 2018 | 1326 | 0.12 | Why? |
| Enterovirus Infections | 1 | 2017 | 404 | 0.12 | Why? |
| Respirovirus | 1 | 2011 | 122 | 0.11 | Why? |
| Influenza A Virus, H3N2 Subtype | 1 | 2016 | 572 | 0.11 | Why? |
| Combined Modality Therapy | 1 | 2020 | 3395 | 0.11 | Why? |
| Stem Cells | 1 | 2017 | 595 | 0.11 | Why? |
| Cytomegalovirus Infections | 1 | 2017 | 667 | 0.11 | Why? |
| Human bocavirus | 1 | 2011 | 142 | 0.11 | Why? |
| Fatal Outcome | 1 | 2020 | 3438 | 0.11 | Why? |
| Population Surveillance | 2 | 2018 | 4967 | 0.10 | Why? |
| Environment | 1 | 2017 | 769 | 0.10 | Why? |
| Shock, Septic | 1 | 2020 | 1313 | 0.10 | Why? |
| Infant | 7 | 2021 | 30274 | 0.10 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 1573 | 0.10 | Why? |
| Antifungal Agents | 1 | 2020 | 1828 | 0.10 | Why? |
| Reagent Kits, Diagnostic | 1 | 2020 | 2149 | 0.10 | Why? |
| Asymptomatic Infections | 4 | 2020 | 7218 | 0.09 | Why? |
| Immunity | 1 | 2020 | 2651 | 0.09 | Why? |
| Child | 9 | 2021 | 70012 | 0.09 | Why? |
| Metapneumovirus | 1 | 2011 | 465 | 0.09 | Why? |
| Humans | 29 | 2021 | 930598 | 0.09 | Why? |
| Viral Load | 4 | 2021 | 15850 | 0.09 | Why? |
| Interferons | 1 | 2020 | 2885 | 0.09 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.09 | Why? |
| Contact Tracing | 4 | 2021 | 8448 | 0.09 | Why? |
| Respiratory Syncytial Viruses | 1 | 2011 | 612 | 0.08 | Why? |
| Interferon Type I | 1 | 2020 | 2789 | 0.08 | Why? |
| Phylogeny | 2 | 2017 | 13341 | 0.08 | Why? |
| Seasons | 2 | 2018 | 4071 | 0.08 | Why? |
| Male | 15 | 2021 | 367725 | 0.08 | Why? |
| Serologic Tests | 1 | 2021 | 4359 | 0.08 | Why? |
| Drug Therapy, Combination | 1 | 2020 | 7268 | 0.08 | Why? |
| Infant, Newborn | 6 | 2021 | 23105 | 0.08 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.08 | Why? |
| Parkinson Disease | 1 | 2018 | 1414 | 0.08 | Why? |
| Waste Water | 1 | 2017 | 2185 | 0.08 | Why? |
| Young Adult | 8 | 2021 | 93724 | 0.08 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.08 | Why? |
| Rhinovirus | 1 | 2011 | 979 | 0.07 | Why? |
| Anti-Bacterial Agents | 2 | 2020 | 10083 | 0.07 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.07 | Why? |
| Adenoviridae | 1 | 2011 | 1151 | 0.07 | Why? |
| Viruses | 1 | 2018 | 2238 | 0.07 | Why? |
| Adolescent | 8 | 2021 | 86841 | 0.07 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.07 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.07 | Why? |
| Immunocompromised Host | 1 | 2020 | 5150 | 0.07 | Why? |
| Case-Control Studies | 3 | 2018 | 17671 | 0.07 | Why? |
| Adult | 10 | 2021 | 244371 | 0.06 | Why? |
| Time-to-Treatment | 1 | 2020 | 5883 | 0.06 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.06 | Why? |
| Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.06 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.06 | Why? |
| Epidemiological Monitoring | 1 | 2016 | 3493 | 0.06 | Why? |
| Vulnerable Populations | 1 | 2016 | 3099 | 0.06 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.06 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 13720 | 0.06 | Why? |
| Vaccination | 2 | 2018 | 19050 | 0.06 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2016 | 2984 | 0.06 | Why? |
| Female | 13 | 2021 | 380317 | 0.06 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.05 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.05 | Why? |
| Disease Outbreaks | 2 | 2020 | 27595 | 0.05 | Why? |
| DNA, Viral | 1 | 2011 | 2521 | 0.05 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.05 | Why? |
| Models, Biological | 1 | 2017 | 4907 | 0.05 | Why? |
| DNA Probes | 1 | 2020 | 178 | 0.05 | Why? |
| Biomedical Research | 1 | 2020 | 5270 | 0.05 | Why? |
| Occupational Exposure | 1 | 2018 | 4742 | 0.05 | Why? |
| Research Design | 1 | 2016 | 5830 | 0.05 | Why? |
| Influenza A virus | 1 | 2011 | 2234 | 0.05 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.05 | Why? |
| Antigens, Viral | 1 | 2016 | 6298 | 0.05 | Why? |
| Tumor Cells, Cultured | 1 | 2018 | 254 | 0.05 | Why? |
| Middle Aged | 8 | 2021 | 270681 | 0.05 | Why? |
| Respiration, Artificial | 2 | 2021 | 22116 | 0.05 | Why? |
| Epidemics | 1 | 2018 | 6407 | 0.04 | Why? |
| Coinfection | 1 | 2018 | 6820 | 0.04 | Why? |
| Aged | 8 | 2021 | 215776 | 0.04 | Why? |
| Pathology, Molecular | 1 | 2020 | 343 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Microarray Analysis | 1 | 2018 | 262 | 0.04 | Why? |
| Health Policy | 1 | 2016 | 6242 | 0.04 | Why? |
| DNA Primers | 1 | 2020 | 1170 | 0.04 | Why? |
| Travel | 1 | 2014 | 7220 | 0.04 | Why? |
| Family Health | 1 | 2020 | 731 | 0.04 | Why? |
| Economic Recession | 1 | 2020 | 453 | 0.03 | Why? |
| Salts | 1 | 1994 | 44 | 0.03 | Why? |
| Staphylococcus | 1 | 1994 | 77 | 0.03 | Why? |
| Coronavirus | 2 | 2014 | 18339 | 0.03 | Why? |
| China | 1 | 2020 | 50654 | 0.03 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2015 | 8843 | 0.03 | Why? |
| Length of Stay | 2 | 2021 | 11042 | 0.03 | Why? |
| Oropharynx | 1 | 2021 | 1581 | 0.03 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 11367 | 0.03 | Why? |
| Molecular Epidemiology | 1 | 2018 | 1638 | 0.03 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2018 | 1887 | 0.03 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.03 | Why? |
| Phosphoproteins | 1 | 2021 | 4346 | 0.03 | Why? |
| Delayed Diagnosis | 1 | 2020 | 1529 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2016 | 15909 | 0.03 | Why? |
| Gene Expression | 1 | 2020 | 3332 | 0.03 | Why? |
| Enterobacteriaceae | 1 | 1994 | 395 | 0.03 | Why? |
| Genes, Viral | 1 | 2015 | 1428 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2021 | 3567 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2020 | 3788 | 0.02 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.02 | Why? |
| Syndrome | 1 | 2014 | 1310 | 0.02 | Why? |
| Pseudomonas aeruginosa | 1 | 1994 | 652 | 0.02 | Why? |
| Diagnostic Tests, Routine | 1 | 2020 | 2643 | 0.02 | Why? |
| Open Reading Frames | 1 | 2015 | 1898 | 0.02 | Why? |
| Health Personnel | 1 | 2018 | 29646 | 0.02 | Why? |
| Viral Envelope Proteins | 1 | 2020 | 3539 | 0.02 | Why? |
| Animals | 1 | 2017 | 78931 | 0.02 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.02 | Why? |
| Prevalence | 2 | 2018 | 25773 | 0.02 | Why? |
| Intubation, Intratracheal | 1 | 2021 | 3962 | 0.02 | Why? |
| Immunoassay | 1 | 2021 | 4485 | 0.02 | Why? |
| Microbial Sensitivity Tests | 1 | 1994 | 2886 | 0.02 | Why? |
| Cohort Studies | 2 | 2018 | 36005 | 0.02 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.02 | Why? |
| RNA, Viral | 1 | 2011 | 32276 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2021 | 9091 | 0.02 | Why? |
| Europe | 1 | 2020 | 12702 | 0.02 | Why? |
| Saudi Arabia | 1 | 2014 | 4423 | 0.02 | Why? |
| Diarrhea | 1 | 2014 | 2743 | 0.01 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
| Molecular Diagnostic Techniques | 1 | 2018 | 4239 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2018 | 8248 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.01 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.01 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.01 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.01 | Why? |
| Fever | 1 | 2014 | 7795 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Viral Proteins | 1 | 2015 | 7370 | 0.01 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.01 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.01 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.01 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.01 | Why? |
| Treatment Outcome | 1 | 2014 | 51732 | 0.01 | Why? |